The 10 Most Influential Multispeciality Hospitals The 10 Most Influential Multispecialty Hospital Sm | Page 17

one was able to help him out with a bloodless transplant.
The benefits of this process are that there is no need for
donors, fewer chances of spreading infection, reduced
cost and no chances of severe diseases that are otherwise
possible in blood transfusion. The patient was charged
almost US$100,000 (approx. INR 45 lakh), but he only
paid around INR 15 lakh at HCG. The right treatment
and affordable care make us the go-to hospital for cancer
treatment.
5. Having stood against cancer for years, how do
you think India has progressed in providing
better cancer treatment for all? What more needs
to be done?
Cancer still is one of the dreaded ailments. We have
seen significant changes in the approach of cancer
care in the last couple of decades. It has moved from
evidence-based medicine to personalized care with
the help of improved modalities for treatment leading
to better outcomes. The advent of advanced new
technologies has changed the way doctors and
patients can approach radiation, making it a safer and
more effective form of treatment. The use of artificial
intelligence – that has taken the healthcare industry
by storm helps in improving early detection of breast
cancer, and it is helping scientists to predict what
combinations of the existing drugs may work in
different types of cancer.
6. What are various scientific and technological
developments in healthcare industry? How do
you ensure to stay updated and leverage these to
provide better care?
An unparalleled pace of technological advancement
has already made inroads in the healthcare sector.
Innovations in the digital space have now enabled
individuals to remotely monitor heartbeat, blood
pressure readings, rate & depth of breathing and a
host of other things. Technologies are aiding
doctors/physicians in diagnostics and determining the
problems.
7. What are your major threats and challenges?
What has been your strategy to overcome these?
Even though things have improved over the years, in
the past, regulatory issues and lack of transparency
in the system made it difficult to get the necessary
plan approvals and in making sure that the
governance in each state is addressed. When it takes
2-3 years to build a single cancer centre, these
concerns really hamper our execution of multiple
cancer centres across India. Very few people in the
world have managed to get it right, including MD
Anderson which is a single centre. Getting the right
talent was also a challenge that we overcame by
making it doctor-centric. We rope in doctors who are
not just treating the disease but also show interest in
research. Bringing in the necessary technology is a
huge motivational factor for these doctors.
8. What have been your major accomplishments?
Please mention any awards or accolades you have
received so far, if any.
We are the first hospital in India to receive the
Golden Peacock Award – in Innovation Management.
We have bagged the award of ‘The Most Innovative
Single Speciality Healthcare Entity’ by VCCIRCLE;
won the Frost & Sullivan Oncology ‘Leader of the
Year’ 2 times in a row; won ‘Best Health Care Group
of The Year’ by BMA. In 2014, we also won the Best
Marketing Campaign for SelfV Survivor Stories at
the Asian Healthcare Leadership Awards 2014.
9. What are your future plans for the company?
Where do you see the company in the years to
come?
Presently, we have 26 oncology hospitals across the
country, and we are coming up with our centers in
Delhi, Mumbai, and Kolkata. We are also into multi-
specialty and coming up with our fifth center. We
feel our fertility chain Milann is rated number one
and see significant opportunities to grow. In the near
future, we are looking forward to creating a
multi-specialty with entrepreneurs.
| March 2019 | 15